Literature DB >> 20222171

T300A polymorphism of ATG16L1 and susceptibility to inflammatory bowel diseases: a meta-analysis.

Jia-Fei Cheng1, Yue-Ji Ning, Wei Zhang, Zong-Hai Lu, Lin Lin.   

Abstract

AIM: To evaluate the association of the autophagy-related 16-like 1 (ATG16L1) T300A polymorphism (rs2241880) with predisposition to inflammatory bowel diseases (IBD) by means of meta-analysis.
METHODS: Publications addressing the relationship between rs2241880/T300A polymorphism of ATG16L1 and Crohn's disease (CD) and ulcerative colitis (UC) were selected from the MEDLINE and EMBASE databases. To make direct comparisons between the data collected in these studies, the individual authors were contacted when necessary to generate a standardized set of data from these studies. From these data, odds ratio (OR) with 95% confidence interval (CI) were calculated.
RESULTS: Twenty-five studies of CD were analyzed, 14 of which involved cases of UC. The variant G allele of ATG16L1 was positively associated with CD (OR = 1.32, 95% CI: 1.26-1.39, P < 0.00001) and UC (OR = 1.06, 95% CI: 1.01-1.10, P = 0.02). For child-onset IBD, a higher G allele frequency was found for cases of CD (OR = 1.35, 95% CI: 1.16-1.57, P = 0.0001) than for cases of UC (OR = 0.98, 95% CI: 0.81-1.19, P = 0.84) relative to controls.
CONCLUSION: The ATG16L1 T300A polymorphism contributes to susceptibility to CD and UC in adults, but different in children, which implicates a role for autophagy in the pathogenesis of IBD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20222171      PMCID: PMC2839180          DOI: 10.3748/wjg.v16.i10.1258

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  64 in total

Review 1.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 2.  Autophagy: process and function.

Authors:  Noboru Mizushima
Journal:  Genes Dev       Date:  2007-11-15       Impact factor: 11.361

3.  Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.

Authors:  Toshihiko Okazaki; Ming-Hsi Wang; Patricia Rawsthorne; Michael Sargent; Lisa Wu Datta; Yin Yao Shugart; Charles N Bernstein; Steven R Brant
Journal:  Inflamm Bowel Dis       Date:  2008-11       Impact factor: 5.325

4.  [Correlation of the autophagosome gene ATG16L1 polymorphism and inflammatory bowel disease].

Authors:  Jia Zhi; Fa-chao Zhi; Zheng-yan Chen; Guo-peng Yao; Jing Guan; Yong Lin; Ying-chun Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2008-04

5.  Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis.

Authors:  M Boirivant; M Marini; G Di Felice; A M Pronio; C Montesani; R Tersigni; W Strober
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

6.  Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.

Authors:  R K Weersma; P C F Stokkers; A A van Bodegraven; R A van Hogezand; H W Verspaget; D J de Jong; C J van der Woude; B Oldenburg; R K Linskens; E A M Festen; G van der Steege; D W Hommes; J B A Crusius; C Wijmenga; I M Nolte; G Dijkstra
Journal:  Gut       Date:  2008-09-29       Impact factor: 23.059

7.  Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy.

Authors:  Anna Latiano; Orazio Palmieri; Maria Rosa Valvano; Renata D'Incà; Salvatore Cucchiara; Gabriele Riegler; Anna Maria Staiano; Sandro Ardizzone; Salvatore Accomando; Gian Luigi de Angelis; Giuseppe Corritore; Fabrizio Bossa; Vito Annese
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

8.  CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease.

Authors:  Nicolas Barnich; Frédéric A Carvalho; Anne-Lise Glasser; Claude Darcha; Peter Jantscheff; Matthieu Allez; Harald Peeters; Gilles Bommelaer; Pierre Desreumaux; Jean-Frédéric Colombel; Arlette Darfeuille-Michaud
Journal:  J Clin Invest       Date:  2007-05-24       Impact factor: 14.808

9.  Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease.

Authors:  Subra Kugathasan; Robert N Baldassano; Jonathan P Bradfield; Patrick M A Sleiman; Marcin Imielinski; Stephen L Guthery; Salvatore Cucchiara; Cecilia E Kim; Edward C Frackelton; Kiran Annaiah; Joseph T Glessner; Erin Santa; Tara Willson; Andrew W Eckert; Erin Bonkowski; Julie L Shaner; Ryan M Smith; F George Otieno; Nicholas Peterson; Debra J Abrams; Rosetta M Chiavacci; Robert Grundmeier; Petar Mamula; Gitit Tomer; David A Piccoli; Dimitri S Monos; Vito Annese; Lee A Denson; Struan F A Grant; Hakon Hakonarson
Journal:  Nat Genet       Date:  2008-08-31       Impact factor: 38.330

10.  ATG16L1 T300A polymorphism and Crohn's disease susceptibility: evidence from 13,022 cases and 17,532 controls.

Authors:  Hai-Feng Zhang; Li-Xin Qiu; Yu Chen; Wa-Li Zhu; Chen Mao; Li-Guang Zhu; Ming-Hua Zheng; Yan Wang; Lei Lei; Jian Shi
Journal:  Hum Genet       Date:  2009-04-01       Impact factor: 4.132

View more
  13 in total

1.  Antibacterial autophagy occurs at PI(3)P-enriched domains of the endoplasmic reticulum and requires Rab1 GTPase.

Authors:  Ju Huang; Cheryl L Birmingham; Shahab Shahnazari; Jessica Shiu; Yiyu T Zheng; Adam C Smith; Kenneth G Campellone; Won Do Heo; Samantha Gruenheid; Tobias Meyer; Matthew D Welch; Nicholas T Ktistakis; Peter Kijun Kim; Daniel J Klionsky; John H Brumell
Journal:  Autophagy       Date:  2011-01-01       Impact factor: 16.016

2.  A SPECIAL MEETING REVIEW EDITION: Highlights in Anti-Tumor Necrosis Factor Monitoring and Antibody Monitoring From the 2014 DDW Meeting: Digestive Disease Week 2014 May 3-6, 2014 • Chicago, Illinois: Special Reporting on:• Therapeutic Monitoring of Anti-TNF Levels and Antibodies to Predict Response and Achieve Mucosal Healing• Prospective Therapeutic Drug Monitoring and Optimization of Infliximab Maintenance Therapy in IBD• Classification of Non-IBD, Crohn's Disease and Ulcerative Colitis in a Young Patient Population Using a Multi-Marker Diagnostic Panel• Persistence of Antibodies to Infliximab for More Than Two Months Predicts Loss of Response to Infliximab in Inflammatory Bowel Diseases• Pre-Operative Serological Markers May Predict Postoperative Crohn's Disease Recurrence: Results From a Prospective Mono-Centric Trial• Antibodies and Levels of Biologies-Reactive vs Proactive Measurements• Higher 6-Thioguanine Nucleotide Concentrations Are Associated With Higher Trough Levels of Infliximab in Patients on Combination Therapy• The Clinical and Immunological Significance of Low Levels of Infliximab in the Absence of Anti-lnfliximab Antibodies in Patients With IBD• Antibodies to Adalimumab Predict Inflammation in Crohn's Patients on Maintenance Adalimumab Therapy• ATG16L1 Genotype Is Associated With Response to Anti-TNFWith Expert Commentary by:William J. Sandborn, MDProfessor and Chief, Division of Gastroenterology Director, UCSD IBD CenterUC San Diego Health SystemLa Jolla, California.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-07

3.  Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 4.  The many roles of NOX2 NADPH oxidase-derived ROS in immunity.

Authors:  Grace Y Lam; Ju Huang; John H Brumell
Journal:  Semin Immunopathol       Date:  2010-08-28       Impact factor: 9.623

5.  Prevalence of genetic variants associated with inflammatory bowel disease in a healthy First Nations cohort.

Authors:  Travis B Murdoch; Charles N Bernstein; Hani El-Gabalawy; Joanne M Stempak; Michael Sargent; Brenda Elias; Wei Xu; Saad Pathan; Mark S Silverberg
Journal:  CMAJ       Date:  2012-04-10       Impact factor: 8.262

6.  UEG Week 2020 Oral Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

7.  Detection of Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease is unrelated to the presence of single nucleotide polymorphisms rs2241880 (ATG16L1) and rs10045431 (IL12B).

Authors:  James P Dalton; Alan Desmond; Fergus Shanahan; Colin Hill
Journal:  Med Microbiol Immunol       Date:  2014-02-13       Impact factor: 3.402

8.  Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.

Authors:  Scott Plevy; Mark S Silverberg; Steve Lockton; Tom Stockfisch; Lisa Croner; Jordan Stachelski; Michelle Brown; Cheryl Triggs; Emil Chuang; Fred Princen; Sharat Singh
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

9.  Polymorphisms in autophagy genes and susceptibility to tuberculosis.

Authors:  Mario Songane; Johanneke Kleinnijenhuis; Bachti Alisjahbana; Edhyana Sahiratmadja; Ida Parwati; Marije Oosting; Theo S Plantinga; Leo A B Joosten; Mihai G Netea; Tom H M Ottenhoff; Esther van de Vosse; Reinout van Crevel
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

10.  Polymorphisms in autophagy genes are associated with paget disease of bone.

Authors:  Ricardo Usategui-Martín; Judith García-Aparicio; Luis Corral-Gudino; Ismael Calero-Paniagua; Javier Del Pino-Montes; Rogelio González Sarmiento
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.